MIR4662B

Across TCGA pan-cancer cohorts, MIR4662B RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR4662B data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR4662B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4662B expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

OV, KIRC, and ESCA are the cancer types where MIR4662B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.250	0.693	.002	108	view →
KIRC	OS	Tertile	II,III,IV	0.016	0.806	<.001	66	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
BLCA	DFS	Tertile	IV	0.624	0.193	.024	21	view →
LIHC	OS	Tertile	All	0.166	0.688	.033	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR4662B–OV (OS)

Open the OV breakdown →